Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch

Reuters
09/12
Modular Medical Inc. Announces Successful Completion of Clinical Study for MODD1 Pump, Paving Way for Pivot Pump Launch

Modular Medical Inc. has announced the successful completion of a clinical study involving its MODD1 insulin pump, which was tested by nine clinicians with Type 1 diabetes. The study aimed to gather real-world experience and feedback to refine the device for the launch of its next-generation Pivot pump product. The MODD1 pump is designed to provide an easy-to-use and affordable insulin delivery solution for the adult "almost-pumpers" market. Modular Medical plans to submit the Pivot pump to the U.S. Food and Drug Administration for clearance in October 2025. The company expresses gratitude to the participating clinicians and intends to demonstrate improvements in usability in future trials with the Pivot pump.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modular Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1072005) on September 11, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10